肺移植术后限制性移植肺功能综合征:新的影像学见解
回顾性分析22例临床诊断限制性移植肺功能综合征(RAS)患者移植后全部CT,诊断基于FEV1下降≥20%且TLC下降≥10%;发现两种CT模式:14例诊断前平均13.9个月出现主要累及上叶的非消退结节和网状影,8例诊断前平均2.8个月突发主要累及上下叶的弥漫实变;两组移植肺存活期不同。
要点
- RAS诊断前可出现两种CT模式:非消退结节和网状影(主要上叶)或突发弥漫实变(主要上下叶)。
- 非消退结节和网状影组从异常出现到RAS诊断平均13.9个月,移植肺中位存活33.5个月。
- 突发弥漫实变组从异常出现到RAS诊断平均2.8个月,移植肺中位存活6.4个月。
核心结论
- RAS并非单一均质群体,存在慢进展和快进展两组,两组CT异常出现和进展模式不同,且与不同移植肺存活率相关。
研究设计与样本
- 回顾性研究,纳入22例临床诊断RAS的肺移植患者,诊断基于FEV1下降≥20%和TLC下降≥10%的组合;分析移植后所有可用CT扫描,观察肺部异常的出现和演变。
关键影像表现/征象
- 14例患者出现非消退结节和网状影,主要累及上叶,平均在RAS诊断前13.9个月出现。
- 8例患者突发弥漫实变,主要累及上下叶,平均在RAS诊断前2.8个月出现。
诊断标准与关键数值
- RAS临床诊断标准:FEV1下降≥20%且TLC下降≥10%。
- 非消退结节和网状影组:从异常出现起移植肺中位存活33.5个月,多数患者(9/14)仍在随访。
- 突发弥漫实变组:从异常首次出现起移植肺中位存活6.4个月,多数患者(6/8)发生移植肺丢失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To describe the CT changes in patients with restrictive allograft syndrome (RAS) after lung transplantation, before and after clinical diagnosis.
METHODS: This retrospective study included 22 patients with clinical diagnosis of RAS. Diagnosis was based on a combination of forced expiratory volume (FEV1) decline (≥20 %) and total lung capacity (TLC) decline (≥10 %). All available CT scans after transplantation were analyzed for the appearance and evolution of lung abnormalities.
RESULTS: In 14 patients, non-regressing nodules and reticulations predominantly affecting the upper lobes developed an average of 13.9 months prior to the diagnosis of RAS. Median graft survival after onset of non-regressing abnormalities was 33.5 months, with most patients in follow-up (9/14). In eight patients, a sudden appearance of diffuse consolidations mainly affecting both upper and lower lobes was seen an average of 2.8 months prior to the diagnosis of RAS. Median graft survival was 6.4 months after first onset of non-regressing abnormalities, with graft loss in most patients (6/8).
CONCLUSIONS: RAS has been previously described as a homogenous group. However, our study shows two different groups of RAS-patients: one with slow progression and one with fast progression. The two groups show different onset and progression patterns of CT abnormalities.
KEY POINTS: • RAS is the newest discovered form of chronic lung allograft dysfunction (CLAD). • RAS is not a homogenous group, as survival varies greatly between patients. • In this study, we see two different CT onset and progression patterns. • These two different CT patterns also correlate with a different survival rate.
引用
- Dubbeldam A, Barthels C, Coolen J, et al. Restrictive allograft syndrome after lung transplantation: new radiological insights. Eur Radiol. 2016. PMID: 27878373. doi:10.1007/s00330-016-4643-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。